ANOTHER MATTER OF LIFE AND DEATH
Mike Fumento has written two important columns that deserve more attention:
- “Diabetes Foundation Loses its Way”
- “Is Diabetes Cure a Buck Too Far?”
The gist of the columns is that the Juvenile Diabetes Research Foundation International (JDRF) has been so focused on the potential of embryonic stem cell (ESC) research that it has ignored more promising avenues of research based on adult stem cell (ASC) therapies.
Fumento highlights the plight of Dr. Denise Faustman, an eminent Harvard researcher rejected repeatedly by the JDRF. Faustman “was the first to cure diabetes in mice and now seeks funds for a clinical trial to replicate her fantastic results in humans. Thrice she has applied to JDRF; thrice they have rejected her. Never mind her impeccable credentials and that she even reviewed grants for JDRF.”
Her sin, according to Fumento, “seems to be that her treatment involves restoring dead insulin-producing cells in the pancreas with ASCs already present in the body. Despite what the JDRF would have you think, there have already been tremendous breakthroughs in ASC therapy, with over 80 treatments and almost 300 human clinical trials underway – versus zero treatments or trials for ESCs. Still, nothing would belie the false claims of ESC lobbyists more than curing diabetes with ASCs.”
According to Fumento, his syndicate, Scripps Howard News Service, declined to publish the second of the two columns. Fumento says his editor described it as a “diatribe.”
Wesley Smith, an author of numerous books on medical ethics, responds:
What? Fumento’s tone is utterly reasonable. The facts about which he opines are indisputable. Indeed, SCIENCE DID publish the study demonstrating that adult spleen stem cells completely cured mice with late stage juv. diabetes. Despite this amazing success, the JDRF DID refuse to fund human trials. Finally, the JDRF DID fund Proposition 71, which created a right to therapeutic cloning, to the tune of about $2 million. Yet, even IF that technology EVER becomes an effective treatment for juv. diabetes, it is at least a decade or more away.
This raises an important question: Is the JDRF most interested in finding a cure for juvenile diabetes or in promoting embryonic stem cell research and therapeutic human cloning?…
More comment at The Brothers Judd and The Reform Club.
You must be logged in to post a comment.
Obama Chief of Staff: No More Compromise on Contraceptive Mandate
February 12, 2012 04:26 PM by Doug Powers
84 CommentsChoosing Life and Beating the Odds
February 11, 2012 11:50 AM by Doug Powers
32 CommentsObama’s fraudulent abortion mandate “accommodation” Updated: Prez condemns “cynical” opposition
February 10, 2012 10:05 AM by Michelle Malkin
245 Comments‘To Stop the Multiplication of the Unfit’
February 10, 2012 09:06 AM by Michelle Malkin
194 CommentsFormer Democrat Rep. Regrets Vote for Obamacare Due to Contraceptive Coverage
February 7, 2012 03:40 PM by Doug Powers
75 CommentsHow to Make a Liberal Politician Stand Up Against Intrusive Government
February 6, 2012 04:28 PM by Doug Powers
95 CommentsYour Friday IRS regulation dump: Obamacare’s job-killing medical device tax
February 3, 2012 04:21 PM by Michelle Malkin
58 CommentsThe SIGA scandal: Calls for investigation mount
January 27, 2012 02:13 PM by Michelle Malkin
58 Comments
Categories: Health care
Babalu Blog
» Greece is Burning
Patterico
» NYT hails the safety net: Poor hardest hit
Daily Caller
» Inside Media Matters: Sources, memos reveal erratic behavior, close coordination with White House and news organizations
Gateway Pundit
» Notre Dame Tells Obama: HHS Mandate Is a ‘Grave Violation of Religious Freedom and Cannot Stand’
AmSpecBlog
» Weekend Political Wrap-Up
JustOneMinute
» I Guess I'm Still Stuck On Stupid
The Hill
» Rep. Ron Paul not conceding Maine vote












See what others have said
Note from Michelle: This section is for comments from michellemalkin.com's community of registered readers. Please don't assume that I agree with or endorse any particular comment just because I let it stand. A reminder: Anyone who fails to comply with my terms of use may lose his or her posting privilege.